A case of delayed oxaliplatin-induced pseudo-obstruction: an atypical presentation of oxaliplatin neurotoxicity

被引:6
|
作者
Vandamme, M. [1 ,2 ]
Pauwels, W. [2 ]
De Bleecker, J. [3 ,4 ]
机构
[1] Univ Hosp Ghent, Dept Internal Med, B-9000 Ghent, Belgium
[2] St Lucas Gen Hosp, Dept Gastroenterol, Ghent, Belgium
[3] Univ Hosp Ghent, Dept Neurol, B-9000 Ghent, Belgium
[4] St Lucas Gen Hosp, Ghent, Belgium
关键词
Autonomic neuropathy; Metastatic colorectal cancer; Neurotoxicity; Oxaliplatin; Pseudo-obstruction;
D O I
10.1179/2295333714Y.0000000110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemotherapy-induced neurotoxicity is a serious complication of cancer treatment. Oxaliplatin, a third-generation platinum drug, has become one of the first-line therapies used in the treatment of metastatic colorectal cancer. Peripheral neuropathy is a common complication of platinum-based chemotherapy. Most commonly a sensory neuropathy occurs with cold-triggered symptoms in the acute phase and numbness and painful paresthesias as a late presentation. Autonomic neurotoxicity and late presentation, months after cessation of the therapy, has rarely been described. We report a patient who clinically presented with a pseudo-obstruction months after treatment with oxaliplatin for metastatic colorectal cancer. Intestinal adhesions and relapsing malignancy were carefully excluded. By exclusion the pseudo-obstruction was attributed to a toxic oxaliplatin-induced autonomic neuropathy which slowly improved during months of follow-up.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [1] OXALIPLATIN-INDUCED NEUROTOXICITY
    Sanchez Marta, Esteban
    Maria Fe, Hurtado Gomez
    Anciano Jara, Gallardo
    Olea Ascension, Alfaro
    ATENCION FARMACEUTICA, 2011, 13 (05): : 280 - +
  • [2] The pathophysiology of oxaliplatin-induced neurotoxicity
    Kiernan, Matthew C.
    Krishnan, Arun V.
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (24) : 2901 - 2907
  • [3] Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
    Velasco, Roser
    Alemany, Montserrat
    Villagran, Macarena
    Argyriou, Andreas A.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (07):
  • [4] Oxaliplatin-induced neurotoxicity and the development of neuropathy
    Krishnan, AV
    Goldstein, D
    Friedlander, M
    Kiernan, MC
    MUSCLE & NERVE, 2005, 32 (01) : 51 - 60
  • [5] Delayed Oxaliplatin-Induced Sensorimotor Polyneuropathy
    Nardone, Raffaele
    Buratti, Thomas
    Golaszewski, Stefan
    Bratti, Arianna
    Caleri, Francesca
    Tezzon, Frediano
    Ladurner, Gunther
    Mitterer, Manfred
    ONKOLOGIE, 2009, 32 (05): : 283 - 285
  • [6] Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
    Argyriou, Andreas A.
    TOXICS, 2015, 3 (02): : 187 - 197
  • [7] A curious case of oxaliplatin-induced neurotoxicity: Recurrent, self-limiting dysarthria
    Joseph, Ranjit
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (05) : 393 - 396
  • [8] Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
    Park, Susanna B.
    Lin, Cindy S. -Y.
    Krishnan, Arun V.
    Goldstein, David
    Friedlander, Michael L.
    Kiernan, Matthew C.
    BRAIN, 2009, 132 : 2712 - 2723
  • [9] Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series
    Gonzalez, Amalia
    Walker, Evan J.
    Van Loon, Katherine
    Cinar, Pelin
    Atreya, Chloe E.
    ANTICANCER RESEARCH, 2020, 40 (02) : 865 - 871
  • [10] Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection
    Wang, Youyu
    Jiang, Bo
    Luo, Wang
    BIOENGINEERED, 2022, 13 (03) : 6688 - 6697